Wark J D
University of Melbourne, Department of Medicine, Royal Melbourne Hospital Victoria, Australia.
Maturitas. 1996 Mar;23(2):193-207. doi: 10.1016/0378-5122(95)00974-4.
To review current knowledge of the epidemiology, pathogenesis, prevention and treatment of osteoporosis, with particular reference to issues related to the menopause.
Peer-reviewed publications were assessed.
Much international variation exists in the prevalence of osteoporosis and the incidence of fracture. Risk fractures for osteoporosis are numerous. The menopause and other causes of hypogonadism in both women and men strongly predispose to osteoporosis. Various endocrinopathies, especially glucocorticoid excess, also are important. The contribution of family history may be explained by one or more genetic markers. Poor vitamin D and calcium nutrition, smoking, high alcohol consumption and inactivity increase risk. Reduced bone mass is a major risk factor for fracture, although the magnitude of that risk may vary between populations. In addition, bone fragility, length of the femoral neck (for hip fracture), history of prior fracture (for vertebral fracture) and falls affect fracture risk. Useful methods for measuring bone density are available for both epidemiologic surveillance and for clinical practice. Dual energy x-ray absorptiometry is the most desirable method in clinical care settings. Some risk factors can be modified for prevention of osteoporosis. Postmenopausal bone loss can be inhibited with estrogen or estrogen plus progestin therapy. Bone loss in the elderly may be moderated with calcium and vitamin D supplementation. Maintenance of muscle tone and strength through exercise may reduce falls. CONCLUSIONS. Osteoporosis is a large and growing health problem in many countries. Prevention of osteoporosis is a high priority, especially because treatment of the established disease remains sub-optimal. Prevention requires immediate, intermediate-term and long-term strategies. First line therapy for established osteoporosis in women in many countries is estrogen or estrogen plus progestin, calcium and vitamin D. Prospects for improved prevention of osteoporotic fractures are encouraging.
回顾骨质疏松症的流行病学、发病机制、预防和治疗的现有知识,特别提及与绝经相关的问题。
评估经同行评审的出版物。
骨质疏松症的患病率和骨折发生率在国际上存在很大差异。骨质疏松症的风险骨折因素众多。绝经以及男女两性性腺功能减退的其他原因极易引发骨质疏松症。各种内分泌疾病,尤其是糖皮质激素过多,也很重要。家族史的影响可能由一种或多种基因标记来解释。维生素D和钙营养不佳、吸烟、大量饮酒和缺乏运动都会增加风险。骨量减少是骨折的主要危险因素,尽管该风险的程度在不同人群中可能有所不同。此外,骨脆性、股骨颈长度(对于髋部骨折)、既往骨折史(对于椎体骨折)和跌倒都会影响骨折风险。有可用于流行病学监测和临床实践的测量骨密度的有用方法。双能X线吸收法是临床护理环境中最理想的方法。一些风险因素可以通过预防骨质疏松症来改变。绝经后骨质流失可以通过雌激素或雌激素加孕激素疗法来抑制。老年人补充钙和维生素D可以减轻骨质流失。通过运动维持肌肉张力和力量可以减少跌倒。结论。骨质疏松症在许多国家是一个庞大且不断加剧的健康问题。预防骨质疏松症是当务之急,特别是因为对已确诊疾病的治疗仍然不尽人意。预防需要短期、中期和长期策略。在许多国家,女性已确诊骨质疏松症的一线治疗方法是雌激素或雌激素加孕激素、钙和维生素D。改善骨质疏松性骨折预防的前景令人鼓舞。